| scholarly article | Q13442814 |
| P356 | DOI | 10.1378/CHEST.119.2_SUPPL.373S |
| P698 | PubMed publication ID | 11171773 |
| P2093 | author name string | Lynch JP 3rd | |
| P433 | issue | 2 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| hospital-acquired pneumonia | Q1957663 | ||
| P304 | page(s) | 373S-384S | |
| P577 | publication date | 2001-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Hospital-acquired pneumonia: risk factors, microbiology, and treatment | |
| P478 | volume | 119 |
| Q31113551 | Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients? |
| Q53970580 | Aerobic Gram-negative Bacillary Pneumonia |
| Q50484768 | Aminoglycosides |
| Q36338182 | Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection |
| Q37679042 | Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum |
| Q24811492 | Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia |
| Q42393853 | Bronchoalveolar lavage fluid cytokine bead array profile for prognostication of ventilated trauma patients |
| Q28239494 | C5a mediates peripheral blood neutrophil dysfunction in critically ill patients |
| Q35678035 | Causative microorganisms of hospital-acquired pneumonia and laboratory procedures for isolation and identification of causative microorganisms |
| Q29040262 | Cefepime |
| Q57462992 | Characterization of host responses during acute lung infection in the lungs and blood and after treatment with the synthetic immunomodulatory peptide IDR-1002 |
| Q37029217 | Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults |
| Q39773469 | Clonality of Bacterial Pathogens Causing Hospital-Acquired Pneumonia |
| Q34309620 | Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model |
| Q54986627 | Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia. |
| Q24803442 | Costs and risk factors for ventilator-associated pneumonia in a Turkish university hospital's intensive care unit: a case-control study |
| Q28071882 | Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia |
| Q46417447 | E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model |
| Q37494966 | Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia |
| Q36894468 | Enterobacteriaceae |
| Q36930855 | Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature |
| Q47132900 | Epidemiology, microbiology and treatment implications in adult patients hospitalized with pneumonia in different regions of China: a retrospective study |
| Q36126509 | Guide to selection of fluoroquinolones in patients with lower respiratory tract infections |
| Q46076297 | Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit |
| Q33359741 | Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity |
| Q36375986 | Human Neutrophil Chemotaxis Is Modulated by Capsule and O Antigen from an Extraintestinal Pathogenic Escherichia coli Strain |
| Q39373943 | Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study |
| Q34269660 | Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia |
| Q27300857 | In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses |
| Q39198890 | Incidence and potential risk factors for hospital-acquired pneumonia in an emergency department of surgery |
| Q60939843 | Incidence of Respiratory Complications Following Lumbar Spine Surgery |
| Q36530445 | Lung epithelium as a sentinel and effector system in pneumonia--molecular mechanisms of pathogen recognition and signal transduction |
| Q39609617 | Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. |
| Q28080078 | Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity? |
| Q36366778 | Nosocomial pneumonia : rationalizing the approach to empirical therapy |
| Q98292358 | Perioperative Assessment of High-Risk Abdominal Surgery: A Case Study |
| Q40046695 | Phenol-Soluble Modulin Peptides Contribute to Influenza A Virus-Associated Staphylococcus aureus Pneumonia. |
| Q34080411 | Prevalence of major infections and adverse outcomes among hospitalized. ST-elevation myocardial infarction patients in Florida, 2006 |
| Q44251526 | Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa |
| Q40289742 | Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids |
| Q42437142 | Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia |
| Q57237748 | Risk factors |
| Q37084772 | Risk factors for mortality in patients admitted to intensive care units with pneumonia |
| Q37166367 | Sepsis induces early alterations in innate immunity that impact mortality to secondary infection |
| Q27324625 | Spacer-free BODIPY fluorogens in antimicrobial peptides for direct imaging of fungal infection in human tissue |
| Q84657307 | Structural characterization of the tobramycin–piperacillin reaction product formed at pH 6.0 |
| Q54445665 | Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model |
| Q42276263 | Surgical Factors Associated with Prolonged Hospitalization after Reconstruction for Oncological Spine Surgery |
| Q56835140 | Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014-2015 |
| Q38694803 | The Relationship of Paranasal Sinus Opacification to Hospital-Acquired Pneumonia in the Neurologic Intensive Care Unit Patient. |
| Q64242823 | The crowd-out effect of a mass casualty incident: Experience from a dust explosion with multiple burn injuries |
| Q43624809 | The effects of Escherichia coli capsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumonia |
| Q34988239 | The future challenges facing the development of new antimicrobial drugs. |
| Q38662137 | The respiratory threat posed by multidrug resistant Gram-negative bacteria |
| Q37098999 | The role of carbapenems in the treatment of severe nosocomial respiratory tract infections |
| Q47887562 | The use of economic modeling to determine the hospital costs associated with nosocomial infections |
| Q82979670 | [Carbapenemases in Pseudomonas spp] |
| Q81103956 | [Clinical guidelines for the treatment of nosocomial pneumonia in Latin America: an interdisciplinary consensus document. Recommendations of the Latin American Thoracic Society] |
Search more.